A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin
Sharon A. Glynn(Dublin City University), Martin Clynes(Dublin City University)
Cited by 46
Related Papers
The Role of Nitric Oxide in Cancer: Master Regulator or NOt?
|International Journal of Molecular Sciences|2020|171
Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways
|Oncotarget|2017|89
COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer
|BMC Cancer|2010|79